Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$44.62 - $62.75 $133,860 - $188,250
3,000 Added 54.55%
8,500 $399,000
Q2 2024

Aug 13, 2024

SELL
$51.17 - $68.18 $900,592 - $1.2 Million
-17,600 Reduced 76.19%
5,500 $297,000
Q1 2024

May 14, 2024

BUY
$60.67 - $89.12 $916,117 - $1.35 Million
15,100 Added 188.75%
23,100 $1.57 Million
Q4 2023

Feb 13, 2024

SELL
$38.62 - $72.18 $1.87 Million - $3.49 Million
-48,400 Reduced 85.82%
8,000 $500,000
Q2 2023

Aug 11, 2023

SELL
$43.47 - $67.77 $3.56 Million - $5.56 Million
-82,000 Reduced 59.25%
56,400 $3.17 Million
Q1 2023

May 12, 2023

SELL
$41.0 - $56.12 $9.72 Million - $13.3 Million
-237,100 Reduced 63.14%
138,400 $6.26 Million
Q4 2022

Feb 10, 2023

SELL
$39.19 - $65.67 $293,925 - $492,525
-7,500 Reduced 1.96%
375,500 $15.3 Million
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $452,140 - $619,972
7,400 Added 1.97%
383,000 $25 Million
Q2 2022

Aug 12, 2022

BUY
$43.23 - $73.83 $1.45 Million - $2.47 Million
33,500 Added 9.79%
375,600 $22.8 Million
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $5.16 Million - $7.69 Million
97,100 Added 39.63%
342,100 $21.5 Million
Q4 2021

Feb 11, 2022

BUY
$70.09 - $111.29 $8.03 Million - $12.7 Million
114,500 Added 87.74%
245,000 $18.6 Million
Q3 2021

Nov 12, 2021

BUY
$110.2 - $156.64 $2.18 Million - $3.1 Million
19,800 Added 17.89%
130,500 $14.6 Million
Q2 2021

Aug 13, 2021

SELL
$100.84 - $161.89 $3.92 Million - $6.3 Million
-38,900 Reduced 26.0%
110,700 $17.9 Million
Q1 2021

May 14, 2021

BUY
$110.72 - $210.04 $16.6 Million - $31.4 Million
149,600 New
149,600 $18.2 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.